BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29600765)

  • 1. Network Pharmacology: Exploring the Resources and Methodologies.
    Muhammad J; Khan A; Ali A; Fang L; Yanjing W; Xu Q; Wei DQ
    Curr Top Med Chem; 2018; 18(12):949-964. PubMed ID: 29600765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network pharmacology of cancer: From understanding of complex interactomes to the design of multi-target specific therapeutics from nature.
    Poornima P; Kumar JD; Zhao Q; Blunder M; Efferth T
    Pharmacol Res; 2016 Sep; 111():290-302. PubMed ID: 27329331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systems pharmacology strategies for drug discovery and combination with applications to cardiovascular diseases.
    Li P; Chen J; Wang J; Zhou W; Wang X; Li B; Tao W; Wang W; Wang Y; Yang L
    J Ethnopharmacol; 2014; 151(1):93-107. PubMed ID: 23850710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer-based targeted therapy.
    Zhu G; Chen X
    Adv Drug Deliv Rev; 2018 Sep; 134():65-78. PubMed ID: 30125604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery.
    Ravikumar B; Aittokallio T
    Expert Opin Drug Discov; 2018 Feb; 13(2):179-192. PubMed ID: 29233023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on action mechanism of adjuvant therapeutic effect compound Ejiao slurry in treating cancers based on network pharmacology].
    Xu HY; Wang SS; Yang HJ; Bian BL; Tian SS; Wang DL; Lu P; Zhou XS; You JH; Huang LQ
    Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(16):3148-51. PubMed ID: 25509304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening drug target combinations in disease-related molecular networks.
    Luo M; Jiao J; Wang R
    BMC Bioinformatics; 2019 May; 20(Suppl 7):198. PubMed ID: 31074386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Human Kinome Targeted by FDA Approved Multi-Target Drugs and Combination Products: A Comparative Study from the Drug-Target Interaction Network Perspective.
    Li YH; Wang PP; Li XX; Yu CY; Yang H; Zhou J; Xue WW; Tan J; Zhu F
    PLoS One; 2016; 11(11):e0165737. PubMed ID: 27828998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Silico Oncology Drug Repositioning and Polypharmacology.
    Cheng F
    Methods Mol Biol; 2019; 1878():243-261. PubMed ID: 30378081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptome inference and systems approaches to polypharmacology and drug discovery in herbal medicine.
    Li P; Chen J; Zhang W; Fu B; Wang W
    J Ethnopharmacol; 2017 Jan; 195():127-136. PubMed ID: 27894972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.
    Zhang W; Bai Y; Wang Y; Xiao W
    Curr Pharm Des; 2016; 22(21):3171-81. PubMed ID: 26907941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From stroke to neurodegenerative diseases: The multi-target neuroprotective effects of 3-n-butylphthalide and its derivatives.
    Huang L; Wang S; Ma F; Zhang Y; Peng Y; Xing C; Feng Y; Wang X; Peng Y
    Pharmacol Res; 2018 Sep; 135():201-211. PubMed ID: 30103000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-Scale Off-Target Identification Using Fast and Accurate Dual Regularized One-Class Collaborative Filtering and Its Application to Drug Repurposing.
    Lim H; Poleksic A; Yao Y; Tong H; He D; Zhuang L; Meng P; Xie L
    PLoS Comput Biol; 2016 Oct; 12(10):e1005135. PubMed ID: 27716836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structural components of Chinese medicine and pharmacology network: systematical overall regulation on pathological network].
    Chen J; Gu JF; Wang CF; Yuan JR; Zhao BJ; Zhang L; Cheng XD; Feng L; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2015 Feb; 40(4):758-64. PubMed ID: 26137704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases.
    Gontijo VS; Viegas FPD; Ortiz CJC; de Freitas Silva M; Damasio CM; Rosa MC; Campos TG; Couto DS; Tranches Dias KS; Viegas C
    Curr Neuropharmacol; 2020; 18(5):348-407. PubMed ID: 31631821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Biological Profiles of Coumarin Scaffold - Part 1.
    de Carvalho da Silva F; Ferreira VF; da Silva Magalhaes Forezi L
    Curr Top Med Chem; 2017; 17(29):3171-3172. PubMed ID: 29475429
    [No Abstract]   [Full Text] [Related]  

  • 17. Systems Pharmacology Dissection of the Integrated Treatment for Cardiovascular and Gastrointestinal Disorders by Traditional Chinese Medicine.
    Zhang W; Tao Q; Guo Z; Fu Y; Chen X; Shar PA; Shahen M; Zhu J; Xue J; Bai Y; Wu Z; Wang Z; Xiao W; Wang Y
    Sci Rep; 2016 Sep; 6():32400. PubMed ID: 27597117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative and Systems Pharmacology. 1. In Silico Prediction of Drug-Target Interactions of Natural Products Enables New Targeted Cancer Therapy.
    Fang J; Wu Z; Cai C; Wang Q; Tang Y; Cheng F
    J Chem Inf Model; 2017 Nov; 57(11):2657-2671. PubMed ID: 28956927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico polypharmacology of natural products.
    Fang J; Liu C; Wang Q; Lin P; Cheng F
    Brief Bioinform; 2018 Nov; 19(6):1153-1171. PubMed ID: 28460068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.